FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $815,202 | -43.9% | 171,261 | -32.8% | 0.04% | -51.1% |
| Q1 2023 | $1,453,437 | +1187.2% | 254,989 | +2178.5% | 0.09% | +1185.7% |
| Q4 2022 | $112,917 | -54.1% | 11,191 | +2.1% | 0.01% | -61.1% |
| Q3 2022 | $246,000 | -10.9% | 10,962 | -1.7% | 0.02% | 0.0% |
| Q2 2022 | $276,000 | -43.1% | 11,154 | -10.8% | 0.02% | -10.0% |
| Q1 2022 | $485,000 | -40.4% | 12,511 | -10.1% | 0.02% | -25.9% |
| Q4 2021 | $814,000 | -11.3% | 13,911 | -10.2% | 0.03% | -12.9% |
| Q3 2021 | $918,000 | +350.0% | 15,495 | +558.2% | 0.03% | +342.9% |
| Q2 2021 | $204,000 | – | 2,354 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |